UniProt ID | LRC59_HUMAN | |
---|---|---|
UniProt AC | Q96AG4 | |
Protein Name | Leucine-rich repeat-containing protein 59 | |
Gene Name | LRRC59 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 307 | |
Subcellular Localization |
Microsome membrane Single-pass type II membrane protein. Endoplasmic reticulum membrane Single-pass type II membrane protein. Nucleus envelope. Localization in the nuclear envelope depends upon the nuclear import machinery, including KPNB1. |
|
Protein Description | Required for nuclear import of FGF1, but not that of FGF2. Might regulate nuclear import of exogenous FGF1 by facilitating interaction with the nuclear import machinery and by transporting cytosolic FGF1 to, and possibly through, the nuclear pores.. | |
Protein Sequence | MTKAGSKGGNLRDKLDGNELDLSLSDLNEVPVKELAALPKATILDLSCNKLTTLPSDFCGLTHLVKLDLSKNKLQQLPADFGRLVNLQHLDLLNNKLVTLPVSFAQLKNLKWLDLKDNPLDPVLAKVAGDCLDEKQCKQCANKVLQHMKAVQADQERERQRRLEVEREAEKKREAKQRAKEAQERELRKREKAEEKERRRKEYDALKAAKREQEKKPKKEANQAPKSKSGSRPRKPPPRKHTRSWAVLKLLLLLLLFGVAGGLVACRVTELQQQPLCTSVNTIYDNAVQGLRRHEILQWVLQTDSQQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MTKAGSKG -------CCCCCCCC | 8.60 | 25944712 | |
2 | Acetylation | ------MTKAGSKGG ------CCCCCCCCC | 29.60 | 25489052 | |
6 | Phosphorylation | --MTKAGSKGGNLRD --CCCCCCCCCCHHH | 32.74 | 21955146 | |
7 | Ubiquitination | -MTKAGSKGGNLRDK -CCCCCCCCCCHHHC | 70.67 | 24816145 | |
14 | Ubiquitination | KGGNLRDKLDGNELD CCCCHHHCCCCCEEC | 41.88 | 21906983 | |
14 | Acetylation | KGGNLRDKLDGNELD CCCCHHHCCCCCEEC | 41.88 | 23236377 | |
23 | Phosphorylation | DGNELDLSLSDLNEV CCCEECCCHHHHCCC | 26.03 | 30266825 | |
25 | Phosphorylation | NELDLSLSDLNEVPV CEECCCHHHHCCCCH | 36.35 | 30266825 | |
33 | Ubiquitination | DLNEVPVKELAALPK HHCCCCHHHHHHCCC | 40.72 | 21906983 | |
33 | 2-Hydroxyisobutyrylation | DLNEVPVKELAALPK HHCCCCHHHHHHCCC | 40.72 | - | |
33 | Acetylation | DLNEVPVKELAALPK HHCCCCHHHHHHCCC | 40.72 | 26051181 | |
40 | Acetylation | KELAALPKATILDLS HHHHHCCCCEEEECC | 60.04 | 26051181 | |
40 | Ubiquitination | KELAALPKATILDLS HHHHHCCCCEEEECC | 60.04 | 23000965 | |
40 | Ubiquitination | KELAALPKATILDLS HHHHHCCCCEEEECC | 60.04 | 21890473 | |
40 | 2-Hydroxyisobutyrylation | KELAALPKATILDLS HHHHHCCCCEEEECC | 60.04 | - | |
47 | Phosphorylation | KATILDLSCNKLTTL CCEEEECCCCCCCCC | 18.47 | 21712546 | |
48 | S-nitrosocysteine | ATILDLSCNKLTTLP CEEEECCCCCCCCCC | 7.28 | - | |
48 | Glutathionylation | ATILDLSCNKLTTLP CEEEECCCCCCCCCC | 7.28 | 22555962 | |
48 | S-nitrosylation | ATILDLSCNKLTTLP CEEEECCCCCCCCCC | 7.28 | 19483679 | |
50 | Acetylation | ILDLSCNKLTTLPSD EEECCCCCCCCCCCC | 52.08 | 26051181 | |
50 | Ubiquitination | ILDLSCNKLTTLPSD EEECCCCCCCCCCCC | 52.08 | 32015554 | |
52 | Phosphorylation | DLSCNKLTTLPSDFC ECCCCCCCCCCCCCC | 28.09 | 28348404 | |
53 | Phosphorylation | LSCNKLTTLPSDFCG CCCCCCCCCCCCCCC | 47.29 | 28348404 | |
56 | Phosphorylation | NKLTTLPSDFCGLTH CCCCCCCCCCCCCHH | 46.56 | 28348404 | |
59 | S-nitrosylation | TTLPSDFCGLTHLVK CCCCCCCCCCHHHHH | 5.39 | 19483679 | |
59 | Glutathionylation | TTLPSDFCGLTHLVK CCCCCCCCCCHHHHH | 5.39 | 22555962 | |
59 | S-nitrosocysteine | TTLPSDFCGLTHLVK CCCCCCCCCCHHHHH | 5.39 | - | |
66 | 2-Hydroxyisobutyrylation | CGLTHLVKLDLSKNK CCCHHHHHHCCCCCH | 42.52 | - | |
66 | Ubiquitination | CGLTHLVKLDLSKNK CCCHHHHHHCCCCCH | 42.52 | 21890473 | |
66 | Ubiquitination | CGLTHLVKLDLSKNK CCCHHHHHHCCCCCH | 42.52 | 22817900 | |
71 | Acetylation | LVKLDLSKNKLQQLP HHHHCCCCCHHHCCC | 66.45 | 23749302 | |
71 | 2-Hydroxyisobutyrylation | LVKLDLSKNKLQQLP HHHHCCCCCHHHCCC | 66.45 | - | |
71 | Ubiquitination | LVKLDLSKNKLQQLP HHHHCCCCCHHHCCC | 66.45 | 23000965 | |
73 | Succinylation | KLDLSKNKLQQLPAD HHCCCCCHHHCCCCC | 51.95 | - | |
73 | Malonylation | KLDLSKNKLQQLPAD HHCCCCCHHHCCCCC | 51.95 | 26320211 | |
73 | Ubiquitination | KLDLSKNKLQQLPAD HHCCCCCHHHCCCCC | 51.95 | 23000965 | |
73 | Ubiquitination | KLDLSKNKLQQLPAD HHCCCCCHHHCCCCC | 51.95 | 21890473 | |
73 | Succinylation | KLDLSKNKLQQLPAD HHCCCCCHHHCCCCC | 51.95 | - | |
73 | 2-Hydroxyisobutyrylation | KLDLSKNKLQQLPAD HHCCCCCHHHCCCCC | 51.95 | - | |
73 | Acetylation | KLDLSKNKLQQLPAD HHCCCCCHHHCCCCC | 51.95 | 23749302 | |
96 | Ubiquitination | HLDLLNNKLVTLPVS HHHHHCCCEEEEECC | 43.17 | 21963094 | |
96 | Acetylation | HLDLLNNKLVTLPVS HHHHHCCCEEEEECC | 43.17 | 26051181 | |
99 | Phosphorylation | LLNNKLVTLPVSFAQ HHCCCEEEEECCHHH | 35.46 | 28102081 | |
103 | Phosphorylation | KLVTLPVSFAQLKNL CEEEEECCHHHHCCC | 16.96 | 28102081 | |
108 | Ubiquitination | PVSFAQLKNLKWLDL ECCHHHHCCCCCCCC | 48.42 | 21963094 | |
108 | Acetylation | PVSFAQLKNLKWLDL ECCHHHHCCCCCCCC | 48.42 | 25953088 | |
108 | 2-Hydroxyisobutyrylation | PVSFAQLKNLKWLDL ECCHHHHCCCCCCCC | 48.42 | - | |
111 | Malonylation | FAQLKNLKWLDLKDN HHHHCCCCCCCCCCC | 55.92 | 26320211 | |
111 | Ubiquitination | FAQLKNLKWLDLKDN HHHHCCCCCCCCCCC | 55.92 | 21890473 | |
111 | Acetylation | FAQLKNLKWLDLKDN HHHHCCCCCCCCCCC | 55.92 | 25825284 | |
111 | 2-Hydroxyisobutyrylation | FAQLKNLKWLDLKDN HHHHCCCCCCCCCCC | 55.92 | - | |
111 | Ubiquitination | FAQLKNLKWLDLKDN HHHHCCCCCCCCCCC | 55.92 | 22817900 | |
116 | 2-Hydroxyisobutyrylation | NLKWLDLKDNPLDPV CCCCCCCCCCCCCHH | 55.94 | - | |
116 | Ubiquitination | NLKWLDLKDNPLDPV CCCCCCCCCCCCCHH | 55.94 | 21906983 | |
116 | Acetylation | NLKWLDLKDNPLDPV CCCCCCCCCCCCCHH | 55.94 | 26051181 | |
126 | 2-Hydroxyisobutyrylation | PLDPVLAKVAGDCLD CCCHHHHHHHHHCCC | 28.58 | - | |
126 | Ubiquitination | PLDPVLAKVAGDCLD CCCHHHHHHHHHCCC | 28.58 | 21963094 | |
126 | Acetylation | PLDPVLAKVAGDCLD CCCHHHHHHHHHCCC | 28.58 | 25953088 | |
131 | Glutathionylation | LAKVAGDCLDEKQCK HHHHHHHCCCHHHHH | 5.16 | 22555962 | |
131 | S-nitrosylation | LAKVAGDCLDEKQCK HHHHHHHCCCHHHHH | 5.16 | 19483679 | |
131 | S-nitrosocysteine | LAKVAGDCLDEKQCK HHHHHHHCCCHHHHH | 5.16 | - | |
135 | 2-Hydroxyisobutyrylation | AGDCLDEKQCKQCAN HHHCCCHHHHHHHHH | 61.74 | - | |
135 | Malonylation | AGDCLDEKQCKQCAN HHHCCCHHHHHHHHH | 61.74 | 26320211 | |
135 | Ubiquitination | AGDCLDEKQCKQCAN HHHCCCHHHHHHHHH | 61.74 | 21963094 | |
135 | Succinylation | AGDCLDEKQCKQCAN HHHCCCHHHHHHHHH | 61.74 | 27452117 | |
135 | Acetylation | AGDCLDEKQCKQCAN HHHCCCHHHHHHHHH | 61.74 | 23749302 | |
138 | Ubiquitination | CLDEKQCKQCANKVL CCCHHHHHHHHHHHH | 46.01 | 22817900 | |
143 | Malonylation | QCKQCANKVLQHMKA HHHHHHHHHHHHHHH | 26.29 | 26320211 | |
143 | Acetylation | QCKQCANKVLQHMKA HHHHHHHHHHHHHHH | 26.29 | 25953088 | |
149 | Ubiquitination | NKVLQHMKAVQADQE HHHHHHHHHHHHHHH | 43.19 | 21963094 | |
149 | Acetylation | NKVLQHMKAVQADQE HHHHHHHHHHHHHHH | 43.19 | 25953088 | |
149 | Malonylation | NKVLQHMKAVQADQE HHHHHHHHHHHHHHH | 43.19 | 26320211 | |
149 | 2-Hydroxyisobutyrylation | NKVLQHMKAVQADQE HHHHHHHHHHHHHHH | 43.19 | - | |
192 | Ubiquitination | RELRKREKAEEKERR HHHHHHHHHHHHHHH | 66.19 | 24816145 | |
201 | 2-Hydroxyisobutyrylation | EEKERRRKEYDALKA HHHHHHHHHHHHHHH | 59.83 | - | |
201 | Ubiquitination | EEKERRRKEYDALKA HHHHHHHHHHHHHHH | 59.83 | 33845483 | |
203 | Phosphorylation | KERRRKEYDALKAAK HHHHHHHHHHHHHHH | 15.00 | 28796482 | |
207 | Malonylation | RKEYDALKAAKREQE HHHHHHHHHHHHHHH | 48.28 | 26320211 | |
207 | Ubiquitination | RKEYDALKAAKREQE HHHHHHHHHHHHHHH | 48.28 | 33845483 | |
207 | Methylation | RKEYDALKAAKREQE HHHHHHHHHHHHHHH | 48.28 | 115972615 | |
207 | Acetylation | RKEYDALKAAKREQE HHHHHHHHHHHHHHH | 48.28 | 25953088 | |
216 | Ubiquitination | AKREQEKKPKKEANQ HHHHHHHCCHHHHHC | 62.41 | 24816145 | |
226 | Ubiquitination | KEANQAPKSKSGSRP HHHHCCCCCCCCCCC | 73.80 | 33845483 | |
305 | Phosphorylation | QWVLQTDSQQ----- HHHHHHCCCC----- | 33.59 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of LRC59_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LRC59_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LRC59_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-111, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23 AND SER-25, AND MASSSPECTROMETRY. |